Side-by-side comparison of AI visibility scores, market position, and capabilities
Westlake OH precision dispensing technology (NASDAQ: NDSN) at record $2.7B FY2024 revenue; semiconductor packaging, medical fluid solutions, and packaging adhesives competing with Graco and ITW for precision manufacturing equipment.
Nordson Corporation is a Westlake, Ohio-based precision dispensing and fluid management technology company — publicly traded on NASDAQ (NASDAQ: NDSN) as an S&P 500 Industrials component — designing and manufacturing equipment for precise application of adhesives, sealants, coatings, biomaterials, and other fluids across electronics assembly, packaging, medical devices, automotive, and industrial manufacturing through approximately 7,500 employees in 35+ countries. In fiscal year 2024, Nordson reported record revenues of $2.7 billion (up 2% year-over-year), net income of $467 million ($8.11 EPS), adjusted EPS of $9.73, with Q4 sales of $744 million (+4%). Nordson guided FY2025 revenue of $2.75-$2.87 billion and adjusted EPS of $9.70-$10.50. Founded in 1954 in Amherst, Ohio by brothers Eric and Evan Nord (whose father Walter Nord had acquired the predecessor company from bankruptcy in 1935), Nordson grew from its origins in airless spray equipment into a Fortune 1000 precision technology leader through 50+ acquisitions. CEO Sundaram "Naga" Nagarajan has led the company since August 2019. Nordson operates through three segments: Industrial Precision Solutions (adhesive and sealant dispensing for packaging, wood assembly, and product manufacturing), Medical and Fluid Solutions (fluid control, single-use biomaterial dispensing, minimally invasive surgical device components), and Advanced Technology Solutions (semiconductor packaging, PCB assembly, and electronics fluid dispensing).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.